Depot formation of doxycycline impairs Tet-regulated gene expression in vivo

Transgenic Research

Volumn 21, Issue 5, 2012, Pages 1099-1107

  Anders, Kathleen ^a   Buschow, Christian ^b   Charo, Jehad ^a   Blankenstein, Thomas ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bioluminescence imaging; Depot formation; Tetracycline system; Transgenic mice

Indexed keywords

ANTINEOPLASTIC AGENT; DOXYCYCLINE; LUCIFERASE; ONCOPROTEIN; TRANSACTIVATOR PROTEIN; VIRUS T ANTIGEN;

ANIMAL; C57BL MOUSE; CROSS BREEDING; DRUG SCREENING; FOUNDER EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUMINESCENCE; METABOLISM; METHODOLOGY; MICROINJECTION; MOUSE; OOCYTE; PROMOTER REGION; REVIEW; SIMIAN VIRUS 40; TANDEM MASS SPECTROMETRY; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTINEOPLASTIC AGENTS; CROSSES, GENETIC; DOXYCYCLINE; DRUG SCREENING ASSAYS, ANTITUMOR; FOUNDER EFFECT; GENE EXPRESSION REGULATION, NEOPLASTIC; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROINJECTIONS; ONCOGENE PROTEINS, FUSION; OOCYTES; PROMOTER REGIONS, GENETIC; SIMIAN VIRUS 40; TANDEM MASS SPECTROMETRY; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSGENES;

MUS; MUS MUSCULUS;

EID: 84865983123     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-011-9580-0     Document Type: Review

References (18)

1. Anders K, Buschow C, Herrmann A, Milojkovic A, Loddenkemper C, Kammertoens T, Daniel P, Yu H, Charo J, Blankenstein T (2011) Oncogene-targeting T cells reject large tumors, while oncogene inactivation selects escape variants in mouse models of cancer. Cancer Cell (in press).
2. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW II, Cordon-Cardo C, Yancopoulos GD, DePinho RA (1999) Essential role for oncogenic Ras in tumour maintenance. Nature 400: 468-472.
3. Dobie K, Mehtali M, McClenaghan M, Lathe R (1997) Variegated gene expression in mice. Trends Genet 13: 127-130.
4. Fulkerson PC, Fischetti CA, Hassman LM, Nikolaidis NM, Rothenberg ME (2006) Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol 35: 337-346.
5. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551.
6. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
7. Hasan MT, Schonig K, Berger S, Graewe W, Bujard H (2001) Long-term, noninvasive imaging of regulated gene expression in living mice. Genesis 29: 116-122.
8. Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005) Ectopic expression of Oct-4 blocks progenitor cell differentiation and causes dysplasia in epithelial tissue. Cell 121: 465-477.
9. Jonkers J, Berns A (2004) Oncogene addiction: sometimes a temporary slavery. Cancer Cell 6: 535-538.
10. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93: 10933-10938.
11. Miyazaki J, Takaki S, Araki K, Tashiro F, Tominaga A, Takatsu K, Yamamura K (1989) Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 79: 269-277.
12. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199.
13. Pao W, Klimstra DS, Fisher GH, Varmus HE (2003) Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance. Proc Natl Acad Sci USA 100: 8764-8769.
14. Schonig K, Schwenk F, Rajewsky K, Bujard H (2002) Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 30: e134.
15. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97: 7963-7968.
16. Wiekowski MT, Chen SC, Zalamea P, Wilburn BP, Kinsley DJ, Sharif WW, Jensen KK, Hedrick JA, Manfra D, Lira SA (2001) Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J Immunol 167: 7102-7110.
17. Willimsky G, Blankenstein T (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437: 141-146.
18. Xie W, Chow LT, Paterson AJ, Chin E, Kudlow JE (1999) Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene 18: 3593-3607.